CD274 and gastric cancer: Immunotherapy based on PD-L1 inhibitors are an important innovation in tumor therapy in recent years, which can reactivate T cell immune functions, increase the body’s immune response capacity and, ultimately, allow the immune system to eliminate gastric cancer tumor cells effectively and achieve tumor remission.